These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12634508)
1. Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults. Zaltzman R; Beni SM; Giladi E; Pinhasov A; Steingart RA; Romano J; Shohami E; Gozes I Neuroreport; 2003 Mar; 14(3):481-4. PubMed ID: 12634508 [TBL] [Abstract][Full Text] [Related]
2. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. Zaltzman R; Alexandrovich A; Trembovler V; Shohami E; Gozes I Peptides; 2005 Aug; 26(8):1520-7. PubMed ID: 16042992 [TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Alcalay RN; Giladi E; Pick CG; Gozes I Neurosci Lett; 2004 May; 361(1-3):128-31. PubMed ID: 15135910 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277 [TBL] [Abstract][Full Text] [Related]
5. NAP prevents acute cerebral oxidative stress and protects against long-term brain injury and cognitive impairment in a model of neonatal hypoxia-ischemia. Greggio S; de Paula S; de Oliveira IM; Trindade C; Rosa RM; Henriques JA; DaCosta JC Neurobiol Dis; 2011 Oct; 44(1):152-9. PubMed ID: 21757007 [TBL] [Abstract][Full Text] [Related]
6. Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model. Idan-Feldman A; Schirer Y; Polyzoidou E; Touloumi O; Lagoudaki R; Grigoriadis NC; Gozes I Neurobiol Dis; 2011 Dec; 44(3):327-39. PubMed ID: 21827858 [TBL] [Abstract][Full Text] [Related]
7. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912 [TBL] [Abstract][Full Text] [Related]
8. NAP accelerates the performance of normal rats in the water maze. Gozes I; Alcalay R; Giladi E; Pinhasov A; Furman S; Brenneman DE J Mol Neurosci; 2002; 19(1-2):167-70. PubMed ID: 12212775 [TBL] [Abstract][Full Text] [Related]
9. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. Gozes I; Giladi E; Pinhasov A; Bardea A; Brenneman DE J Pharmacol Exp Ther; 2000 Jun; 293(3):1091-8. PubMed ID: 10869414 [TBL] [Abstract][Full Text] [Related]
10. A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis. Romano J; Beni-Adani L; Nissenbaum OL; Brenneman DE; Shohami E; Gozes I J Mol Neurosci; 2002; 18(1-2):37-45. PubMed ID: 11931348 [TBL] [Abstract][Full Text] [Related]
11. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides. Li J; Zhang C; Li J; Fan L; Jiang X; Chen J; Pang Z; Zhang Q Pharm Res; 2013 Jul; 30(7):1813-23. PubMed ID: 23549751 [TBL] [Abstract][Full Text] [Related]
12. NAP has no effect on spatial memory after short-term treatment in advanced stage Alzheimer's disease mouse model. Van Dijck A; Van Dam D; De Deyn PP Peptides; 2009 Dec; 30(12):2480-2. PubMed ID: 19664667 [TBL] [Abstract][Full Text] [Related]